Research progress and applications of functional hydrogels in nasal wound healing Authors: Chongyang Wang, Zhikai Wang, Shengqi Gan, Bin He, Yejingwen Tong, Yaojie Zhu, Dong Ye Published: 2026 ABSTRACT AbstractNasal wound healing presents a distinct clinical challenge in otorhinolaryngology, complicated by the unique physicochemical environment of the nasal cavity—including a slightly acidic mucosal pH (≈ 6.3–6.9), shear-thinning mucus rheology (healthy viscosity ≈ 0.1–1 Pa·s, elevated to 1.6–3.2 Pa·s in chronic sinusitis), continuous mucociliary clearance (MCC) with ciliary beat frequencies of ~ 10 Hz, and enzymatic activity dominated by lysozyme. Conventional nasal packing materials—such as Vaseline gauze and polyvinyl alcohol sponges—suffer from poor biocompatibility, rigid mechanical properties, and traumatic removal, failing to satisfy these demanding physicochemical constraints. Functional hydrogels, owing to their tunable viscoelasticity, dynamic covalent or supramolecular crosslinking, and intrinsic responsiveness to pH, reactive oxygen species (ROS), temperature, and enzymes, have emerged as a next-generation solution. This review systematically profiles the physicochemical microenvironment of the nasal wound; reclassifies hydrogel systems by polymer backbone (natural polysaccharides/proteins vs. synthetic polymers) and crosslinking chemistry (dynamic covalent bonds: Schiff base, disulfide, boronic ester vs. supramolecular: host–guest, hydrogen bonding); and examines reaction pathways, degradation kinetics, and mechanical matching with nasal mucosa. Representative systems are critically evaluated, including: (i) the RADA16 self-assembling peptide hydrogel, which in randomized clinical trials reduced postoperative adhesion by 91–100% compared with gelatin–thrombin and bioresorbable controls; (ii) TSPBA/PVA ROS-responsive hydrogels that scavenge H₂O₂ via boronic ester cleavage (second-order rate constant ≈ 0.1–1 M⁻¹·s⁻¹), prolonging mucosal retention to 24 h; (iii) pNIPAAm-based thermoresponsive systems with LCST ≈ 32 °C, the critical implications of which for the physiological nasal temperature range (30–34 °C) are discussed. We further analyze cell–material interactions governing macrophage M1→M2 polarization, epithelial/fibroblast behavior, and ciliary function. Ongoing clinical trials (NCT04970966, NCT05898074) and persistent translational challenges—including sterilization, long-term in vivo safety, and standardized large-scale production—are critically addressed, offering a materials-science-focused framework for the design of next-generation nasal hydrogels.Keywords: Functional hydrogels, Nasal wound healing, Mucociliary clearance, Crosslinking chemistry, Stimuli-responsiveness, Cell–material interactions, Wet tissue adhesion Introduction The nasal cavity is a composite organ characterized by a complex anatomical structure and multiple physiological functions, with its structural integrity reliant on the precise combination of an osteocartilaginous framework and an integumentary-mucosal covering [1]. The nasal mucosa, characterized by its vulnerability and functional susceptibility comprising a rich vascular network, ciliated columnar epithelium, and a mucous layer, is susceptible to complications such as hemorrhage, infection, and impaired healing following trauma, inflammation, or surgical procedures [2]. Clinically, the repair of wounds resulting from epistaxis, nasal polyps, and endoscopic sinus surgery presents significant challenges in achieving effective hemostasis, preventing infection, and avoiding adhesion formation. To prevent complications such as nasal stenosis and blood loss resulting from postoperative adhesions and hemorrhage, clinical practice often involves the insertion of nasal packing materials [3]. However, traditional nasal packing such as Vaseline gauze and tampons, which achieve hemostasis primarily through mechanical pressure, lacks adequate biocompatibility and degradability, leading to secondary trauma and recurrent bleeding upon removal [4]. Critically, these inert materials fail to address the distinctive physicochemical microenvironment of nasal wounds: the shear-thinning rheology of mucus (viscosity 0.1–1 Pa·s in healthy subjects, rising to 1.6–3.2 Pa·s in chronic rhinosinusitis [5, 6]), the hydrodynamic shear stress generated by mucociliary clearance (MCC), the slightly acidic mucosal pH (6.3–6.9) [7], and the enzymatic milieu (lysozyme active at acidic pH) [8]. Consequently, an ideal packing material must offer not only appropriate mechanical properties and a tunable degradation rate but also mucoadhesion matched to the wet epithelial surface, rheological compatibility with mucus clearance, high biocompatibility, rapid hemostatic capability, anti-infective efficacy, and the ability to actively promote wound healing. Functional hydrogels, with their tailorable properties, hold significant potential to overcome the limitations of conventional materials in nasal wound repair. Their tunable viscoelasticity (storage modulus G′ tunable from Pa to kPa), versatile drug-loading capacity, and diverse intelligent responsiveness (pH, ROS, temperature, enzymes, light, etc.) enable rational design against the specific pathological cues of the nasal cavity [9, 10]. Dynamic covalent bonds—such as Schiff bases, disulfides, and boronic esters—confer self-healing and injectability, while supramolecular interactions including host–guest and hydrogen bonding provide mild gelation and reversible adhesion. These features allow hydrogels to function not as passive barriers but as active modulators of the wound microenvironment, enabling spatiotemporally controlled delivery of therapeutic agents at different healing stages [11, 12]. This review adopts a materials-science-focused perspective to systematically summarize recent advances in functional hydrogels for nasal wound healing. We first establish the physicochemical profile of the nasal wound microenvironment as design “gold standards” for materials chemists. We then reclassify hydrogels by polymer backbone and crosslinking chemistry, dissecting their degradation kinetics, rheology, and wet-tissue adhesion. Representative systems are critically evaluated with attention to mechanical robustness under MCC shear, potential toxicity of crosslinkers and degradation byproducts, and clinical translatability. Finally, we analyze cell–material interactions governing healing outcomes and outline the key challenges—sterilization, scale-up, and long-term safety—that remain for clinical translation. Physicochemical profile of the nasal wound microenvironment A rational material design for nasal hydrogels must begin with a quantitative understanding of the microenvironment into which the material will be placed. Unlike skin or bone, the nasal cavity imposes constraints that are simultaneously mechanical, rheological, biochemical, and microbiological. This section translates classical pathological descriptions of nasal injury into physicochemical “design gold standards”—the parameters that dictate crosslinker choice, degradation profile, and mucoadhesive strategy. Wound types and their distinct healing microenvironments Nasal wounds arise from diverse clinical scenarios, each with a distinct physicochemical profile that warrants tailored material design. Post-functional endoscopic sinus surgery (FESS) wounds involve extensive mucosal denudation over the ethmoid and maxillary sinuses, where exudate accumulation, high bacterial load, and MCC disruption predispose to adhesion and crusting [13]. Post-septoplasty wounds are typically bilateral mirror-image defects with mechanical mismatch at the septal plane, where premature displacement of packing can precipitate septal hematoma or perforation [14]. Epistaxis wounds involve acute arterial or venous hemorrhage, requiring hemostatic materials that form rapidly on the wet mucosal surface without relying on extrinsic coagulation [15]. Radiation-induced wounds—most commonly encountered in nasopharyngeal carcinoma (NPC) patients post-radiotherapy—are characterized by chronic oxidative damage, microvascular rarefaction, and fibrosis, requiring materials with antioxidant and pro-angiogenic capacity [16, 17]. These distinct microenvironments preclude a one-size-fits-all hydrogel design; rather, they necessitate modular platforms with adjustable crosslinking, responsiveness, and drug-release kinetics. Inflammatory and oxidative landscape Nasal injuries resulting from trauma, radiotherapy, chronic infections such as rhinosinusitis, or postoperative interventions disrupt mucosal integrity and underlying tissue architecture. The rate and quality of healing are critical for patient recovery, particularly following surgery, where delayed repair can result in secondary complications. Wound formation triggers an intense innate immune response characterized by the rapid infiltration of platelets, neutrophils, and macrophages, which release high concentrations of pro-inflammatory cytokines [18]. While these factors initially serve to clear pathogens and necrotic debris, their persistent overexpression can establish a state of chronic inflammation. This sustained inflammatory milieu directly inhibits epithelial cell migration and proliferation while stimulating excessive collagen production by fibroblasts, ultimately leading to pathological scarring and tissue fibrosis [19, 20]. Concurrently, activated inflammatory cells generate substantial amounts of reactive oxygen species (ROS)—predominantly superoxide (O₂·⁻), hydrogen peroxide (H₂O₂), hydroxyl radical (·OH), and hypochlorite (HOCl)—at pathologically elevated concentrations. Intracellular H₂O₂ typically ranges from 1 to 100 nM in healthy cells but can reach ≈ 610 µM in inflammatory foci compared with a blood baseline of ≈ 3 µM [21]. These markedly elevated ROS concentrations are precisely what ROS-responsive hydrogels are designed to sense and scavenge (see Section “ROS-responsive hydrogels”) [22]. pH, temperature, and enzymatic gold standards In healthy nasal mucosa, the surface-secretion pH is slightly acidic and remarkably stable: mean values of 6.40 ± 0.11 anteriorly and 6.27 ± 0.13 posteriorly, with an overall range of 5.17–8.13 [7, 23]. This acidic baseline supports the antimicrobial activity of lysozyme—which is inactivated under alkaline conditions—and inhibits pathogen adhesion [24]. During acute inflammation, however, the mucosa shifts toward alkalinity, approaching plasma pH 7.4, while the wound itself may transiently acidify due to ischemia, hypoxia, and enhanced anaerobic glycolysis producing lactate [25]. Post-FESS healing correlates with a return to more acidic pH values (mean 5.7 ± 0.9 at 3 months) [26]. These dynamic pH transitions are directly exploitable by pH-responsive hydrogels whose ionization state (governed by the polymer pKa) tunes swelling, drug release, and mucoadhesion (see Section“pH-responsive hydrogels”). The physiological nasal cavity temperature is 30–34 °C, varying with anatomical site and respiration phase; this is substantially below core body temperature [27]. This temperature window is critically below the lower critical solution temperature (LCST) of pNIPAAm-based thermoresponsive systems (≈ 32 °C), creating a narrow and anatomically heterogeneous gelation margin that must be addressed through copolymerization or composite design (see Section “Temperature-responsive hydrogels”). The enzymatic milieu is dominated by lysozyme (molecular weight ≈ 14 kDa, accounting for 5–6% of total lung/nasal protein), lactoferrin, and neutrophil-derived proteases including matrix metalloproteinases (MMPs) [28, 29]. Lysozyme cleaves β-1,4-glycosidic bonds in bacterial peptidoglycan and also in chitosan-based hydrogels, providing an intrinsic, enzyme-triggered degradation route that can be harnessed for controlled release [30]. MMP overexpression at the wound margin enables the design of MMP-cleavable peptide crosslinkers for on-demand drug delivery. Rheology of nasal mucus and hydrodynamics of mucociliary clearance Perhaps the most distinctive—yet most often overlooked—design constraint for nasal hydrogels is the rheological and hydrodynamic environment imposed by MCC. Healthy nasal mucus is a shear-thinning viscoelastic fluid: at a shear frequency of 1 Hz, viscosity η′ ≈ 0.1–1 Pa·s and elastic modulus G′ < 1 Pa [5, 31]. Rheologically, it follows a power-law model with flow consistency index k ≈ 0.355 and flow characteristic index n ≈ 0.482, ensuring shear-thinning behavior that facilitates transport under ciliary beating (≈ 10 Hz, generating local shear rates of 10–20 s⁻¹) [32, 33]. In chronic rhinosinusitis, both η′ (1.6 ± 1.5 Pa·s) and G′ (31.8 ± 31.0 Pa) rise far above the optimal range for MCC (η′ ≈ 0.2 Pa·s), contributing to the vicious cycle of stagnation and inflammation [6]. For a nasal hydrogel, three rheological imperatives follow: (i) upon in situ gelation, the hydrogel must exhibit a G′ sufficiently high to resist displacement by MCC shear yet not so stiff as to mechanically traumatize the mucosa (native mucosal Young’s modulus ≈ 1–10 kPa) [34]; (ii) its degradation products must not significantly alter mucus viscoelasticity, which could paralyze ciliary transport; and (iii) injectable or sprayable formulations must themselves shear-thin to conform to the irregular sinonasal anatomy. Mechanically, compressive stress ≥ 1.0 kPa applied to the epithelial surface can actually enhance ciliary beat frequency through cytoskeletal remodeling [34]; hydrogels tuned to this threshold may therefore actively support mucociliary function rather than inhibit it. Olfactory epithelium: a site of heightened sensitivity The olfactory epithelium, situated at the roof of the nasal cavity, is functionally and structurally distinct from respiratory epithelium: it comprises bipolar olfactory sensory neurons directly exposed to the external environment via their ciliated dendritic knobs. This unique architecture makes the olfactory mucosa particularly sensitive to topical agents; surfactants, preservatives (e.g., benzalkonium chloride), and some polymer degradation products can cause irreversible or long-lasting ciliotoxicity and anosmia [35]. Any hydrogel intended for middle- or superior-meatus application must therefore be characterized for ciliary beat frequency (CBF) preservation and olfactory neuronal compatibility, ideally using air-liquid-interface (ALI) cultures of human nasal epithelial cells (healthy baseline CBF ≈ 7.9 Hz, rising to ~ 11–14 Hz upon full differentiation) [36, 37]. The sinonasal microbiome A further dimension increasingly recognized as modulating nasal wound healing is the sinonasal microbiome. Healthy sinuses harbor a diverse community dominated by commensals such as Corynebacterium spp., Staphylococcus epidermidis, and Propionibacterium/Cutibacterium acnes, which together prime innate immunity and antagonize pathogen overgrowth [38]. In chronic rhinosinusitis, meta-analyses reveal a “bacterial community collapse”—reduced diversity, increased total bacterial load, loss of keystone species, and pathobiont expansion (notably S. aureus and Pseudomonas aeruginosa) [39, 40]. Broad-spectrum antimicrobial hydrogels, while effective against infection, risk exacerbating this dysbiosis; future designs should consider selective antimicrobial mechanisms (e.g., cationic chitosan that spares commensals or hydrogels delivering probiotic-derived bacteriocins) to preserve microbiome homeostasis during healing [41]. Figure 1 integrates the key physicochemical, biological, and microbial parameters of the nasal wound microenvironment, serving as a comprehensive design reference for functional hydrogels. Integrated physicochemical and biological profile of the nasal wound microenvironment. The nasal wound microenvironment imposes multiple design constraints on functional hydrogels, including wound-type-specific anatomy, slightly acidic mucosal pH, a physiological temperature window of approximately 30–34 °C, lysozyme-rich enzymatic activity, reactive oxygen species accumulation during inflammation, shear-thinning mucus rheology, mucociliary clearance-driven hydrodynamic shear, and microbiome dysbiosis in chronic rhinosinusitis. These parameters collectively guide crosslinker selection, gelation kinetics, wet-tissue adhesion, mechanical matching, degradation behavior, and drug-release profiles. Microbiome composition is illustrated schematically to summarize reported trends rather than to represent a single quantitative dataset Classification of functional hydrogels by polymer backbone and crosslinking chemistry The original classification of hydrogels by geometry (“non-microsphere-based” vs. “microgel”) emphasizes form over function and obscures the chemical design principles that actually govern their performance in the nasal cavity. A materials-science-focused review must instead classify hydrogels by (i) the polymer backbone, which dictates intrinsic bioactivity, degradation enzymes, and mechanical baseline; and (ii) the crosslinking chemistry, which governs gelation kinetics, mechanical robustness, self-healing, and—critically for nasal applications—wet tissue adhesion [42, 43]. This section adopts this dual-axis classification and, for each category, discusses how the underlying chemistry translates into function on the moist, dynamic mucosal surface. Hydrogels are composed of hydrophilic three-dimensional networks with tunable water content (typically 90–98%). The backbone defines the baseline properties: natural polysaccharides (chitosan, hyaluronic acid, alginate, dextran) and proteins (collagen, gelatin, silk) offer intrinsic biocompatibility and enzyme-triggered degradation but limited mechanical strength; synthetic polymers (PEG, PVA, pNIPAAm, polyacrylates) provide reproducible molecular weight, tunable crosslinking, and mechanical robustness, at the cost of reduced intrinsic bioactivity [44]. Table 1 summarizes representative nasal hydrogels classified by this new scheme, with key mechanical and kinetic parameters that govern performance. Table 1Representative nasal and nasal-relevant hydrogels classified by polymer backbone, crosslinking chemistry, and key mechanical/kinetic parametersPolymer MatrixCrosslinking MechanismGelation TimeStorage Modulus G’Degradation ProfileDrug/Cargo LoadedKey In Vitro / In Vivo OutcomeReferenceHydroxyethylacrylamide (HEAA) / Diethylacrylamide (DEAA) with acylhydrazone-liposomesFree-radical polymerization + pH-responsive acylhydrazone liposomesIn situ1–5 kPapH-triggered liposome releaseDexamethasone (DXMS)Rabbit nasal mucosal wound: enhanced epithelial regeneration, collagen alignment[67]PMA / PEGH-bonding (pH-responsive)30–60 s0.5–2 kPapH-dependent swellingBudesonideControlled mucosal drug release[68]Chitosan / Dextran aldehyde (CD hydrogel)Schiff base (dynamic covalent)< 1 min1–3 kPaHydrolysis + lysozyme, daysN/A (scaffold)Rabbit cecum + sheep sinus adhesion: 94% reduction[69]TSPBA (diboronic acid) / PVADynamic boronic ester30–90 s0.3–2 kPaROS-triggered (H₂O₂)Ipratropium bromideAllergic rhinitis: 24-h retention, downregulated IL-4/IL-13[61]Tyramine-PVA microspheres (PVATyr MP)Enzymatic (HRP) crosslinking~ 2 min1–4 kPaHydrolytic, weeksCiprofloxacin + dexamethasoneRabbit maxillary sinus: sustained co-release[70]HA-dopamine / 4-formylphenylboronic acid / carboxymethyl chitosan (HAC hydrogel)Dual dynamic covalent boronic ester + imine networkInjectable in situ gelSystem-dependentROS-responsive + hydrolyticDimethyl fumarate (DMF)Bone-defect model: ROS scavenging, reduced inflammatory cytokines, enhanced osteogenesis; chemistry provides a nasal-relevant ROS-responsive design analogue[62]pNIPAAm + PLGA microspheresThermoresponsive (LCST ≈ 32 °C) + hydrolytic microspheres< 1 min at 37 °C0.5–3 kPaBulk erosion, weeks–monthsCorticosteroidParanasal sinus sustained release[71]pNIPAAm / PEGThermoresponsive (LCST ≈ 32 °C)< 1 min1–5 kPaHydrolytic, days–weeksMometasoneExtended sinus delivery[72]Quaternized chitosan / PEGThermoresponsive + electrostatic1–2 min2–8 kPaLysozymalsiRNA, proteinsIntranasal delivery[73]Chitosan / β-glycerophosphateThermoresponsive (ionic)2–5 min0.5–3 kPaLysozymal, weeksmiR-146aAllergic rhinitis: immunomodulation[74]Silk-elastin-like polymer (SELP) + HAThermoresponsive β-sheet assembly + ionic< 1 min1–10 kPaProteolyticSilver nanoparticlesAnti-biofilm vs. S. aureus / P. aeruginosa[51]RADA16 self-assembling peptidePeptide β-sheet H-bonding (supramolecular)< 30 s on contact0.1–0.5 kPaProteolytic, 2–6 weeksScaffold / carrierSheep FESS model: 91–100% synechiae reduction; human RCT: reduced ESS debridement pain[52–54]Chitosan–gluconic acid copolymer (CG)Ionic + H-bonding1–2 min0.5–2 kPaLysozymalN/APilot ESS: superior wound healing vs. commercial dressing[75] Representative nasal and nasal-relevant hydrogels classified by polymer backbone, crosslinking chemistry, and key mechanical/kinetic parameters Natural polymer–based hydrogels Polysaccharide backbones Chitosan is a cationic polysaccharide derived from partial deacetylation of chitin; its primary amine groups are protonated at nasal pH (< pKa ≈ 6.5), generating a cationic density that mediates electrostatic adhesion to negatively charged mucin glycoproteins [45]. This charge-driven mucoadhesion is particularly advantageous on the wet nasal epithelium, where covalent crosslinking to the tissue is chemically difficult. Chitosan is degraded in vivo by lysozyme—abundantly present in nasal secretions—yielding chitooligosaccharides that modulate macrophage polarization and stimulate neutrophil recruitment [46]. However, raw chitosan hydrogels typically exhibit G′ values of 0.1–5 kPa, which may be insufficient to resist MCC shear forces over extended periods (see Section “Rheology of nasal mucus and hydrodynamics of mucociliary clearance”). Hyaluronic acid (HA) is an anionic glycosaminoglycan with intrinsic hygroscopic and lubricating properties. Its negatively charged carboxylate groups complement cationic polymers in forming polyelectrolyte complex hydrogels, and its backbone can be chemically functionalized with methacrylates, thiols, or phenylboronic acid to enable photo-, thiol–ene, or dynamic covalent crosslinking, respectively [47]. HA-based nasal packs (e.g., MeroGel®, cross-linked PureRegen® Gel Sinus) have demonstrated clinical benefit after FESS, including accelerated re-epithelialization and reduced synechiae [48, 49]. Dextran and alginate offer further polysaccharide backbones; oxidized dextran bearing aldehyde groups forms Schiff-base networks with amine-containing polymers (e.g., chitosan, gelatin), producing injectable self-healing hydrogels. Alginate crosslinks ionically with Ca²⁺/Ba²⁺, though the weak coordination renders the resulting hydrogels too fragile for standalone nasal use [50]. Protein backbones Gelatin—denatured collagen—bearing RGD and MMP-cleavable sequences provides cell-adhesive and enzyme-degradable scaffolds; methacryloyl-modified gelatin (GelMA) has become a benchmark photocrosslinkable bioink. Silk fibroin and silk-elastin-like polymers (SELPs) exploit β-sheet self-assembly to produce high-modulus hydrogels with tunable thermoresponsive behavior; SELP-based nasal delivery systems have demonstrated potential in silver-nanoparticle-loaded anti-biofilm applications [51]. Self-assembling peptides, exemplified by the RADA16 sequence (Ac-(RADA)₄-CONH₂), undergo β-sheet assembly into nanofibrous networks at physiological pH and ionic strength, producing extracellular-matrix-mimicking scaffolds without covalent crosslinking. RADA16-based products (PuraGel, PuraSinus) have shown efficacy in multiple nasal clinical trials—including hemostasis, synechiae prevention, and postoperative comfort—and are the most advanced peptide-hydrogel platform in clinical rhinology [52, 53, 54]. Synthetic polymer–based hydrogels Poly(ethylene glycol) (PEG) provides an inert, hydrophilic, non-immunogenic backbone; its functionalization as multi-arm PEG with thiol, maleimide, or norbornene end groups enables rapid, bio-orthogonal crosslinking. Poly(vinyl alcohol) (PVA) offers pendant 1,2-diol groups that readily form dynamic boronic ester linkages with phenylboronic acid (PBA)-modified partners, a chemistry extensively exploited in ROS-responsive nasal hydrogels (Section “ROS-responsive hydrogels”) [55]. Poly(N-isopropylacrylamide) (pNIPAAm) and poloxamers (e.g., Pluronic F127) provide temperature-responsive sol–gel transitions through a coil-to-globule conformational change of the polymer chain, discussed in depth in Section “Temperature-responsive hydrogels”. Zwitterionic polymers—bearing equal numbers of positive and negative charges within each repeating unit (e.g., polycarboxybetaine, polysulfobetaine)—have emerged as a promising class for mucosal applications. Their strong hydration shell confers ultra-low fouling properties, resisting non-specific protein and bacterial adhesion; this is particularly relevant in the nasal cavity, where biofouling by mucin and pathogens is a major cause of hydrogel failure [56, 57]. Zwitterionic dextran-based hydrogels have demonstrated faster wound-healing rates than commercial dressings through a combination of antifouling, antioxidant (free-radical scavenging), and atraumatic removal properties [58]. Classification by crosslinking chemistry Independent of the backbone, the crosslinking chemistry fundamentally determines gelation kinetics, mechanical properties, reversibility, and—most critically—wet tissue adhesion. Dynamic covalent crosslinks Dynamic covalent bonds combine the mechanical strength of covalent networks with the reversibility and adaptability of supramolecular systems, enabling self-healing, injectability, and stimuli-responsiveness. Four dominant chemistries are relevant to nasal hydrogels: Schiff base (imine) bonds form between aldehyde and primary amine groups under mild aqueous conditions (reaction rate constants ~ 10⁻¹ M⁻¹·s⁻¹ at physiological pH). The equilibrium is strongly pH-dependent, favoring hydrolysis at low pH—making Schiff-base hydrogels intrinsically pH-responsive and degradable in acidic inflammatory microenvironments [50]. On mucosal surfaces, aldehyde-bearing polymers (e.g., oxidized HA, oxidized dextran) can react with amine-rich mucin glycoproteins or tissue lysines to form covalent tissue-to-hydrogel bonds, achieving superior wet adhesion [59]. Disulfide bonds (–S–S–) form reversibly from thiol oxidation, with redox-sensitive behavior (cleavage by glutathione or dithiothreitol). Their relevance in nasal hydrogels is primarily in cysteine-containing peptide crosslinkers and thiolated polymers; the reductive environment in wound beds can trigger disulfide cleavage for drug release. Boronic esters form between phenylboronic acid (PBA) and 1,2- or 1,3-diols (e.g., catechols, saccharide residues, PVA diols). The equilibrium constant and stability depend on the PBA pKa (typically 7–9 for arylboronic acids): at nasal-cavity pH (6.3–6.9), most PBAs are predominantly in the trigonal neutral form, favoring ester hydrolysis—a key consideration for gelation efficiency [55, 60]. Crucially, boronic esters undergo ROS-triggered cleavage (detailed kinetics in Section “ROS-responsive hydrogels”), making them the workhorse chemistry for inflammation-responsive nasal hydrogels [61, 62]. Boronate chemistry also enables wet-tissue adhesion via reversible complexation with mucosal catechol and sialic-acid residues. Hydrazone bonds (C = N–N) form between hydrazides and aldehydes/ketones, with slower exchange kinetics than imines and enhanced stability at physiological pH, offering a middle ground between irreversibly covalent and dynamic systems [63]. Supramolecular (Non-Covalent) crosslinks Host–guest interactions between macrocyclic hosts (cyclodextrins, cucurbiturils) and hydrophobic guests (adamantane, ferrocene) provide mild-condition, catalyst-free gelation with tunable strengths. Hydrogen bonding among urea, ureidopyrimidinone (UPy), or peptide β-sheet motifs drives self-assembly as in RADA16. Ionic/electrostatic complexation between oppositely charged polyelectrolytes (e.g., chitosan/hyaluronic acid) produces coacervate-like hydrogels; these are sensitive to ionic strength and can destabilize upon contact with physiological saline—a design constraint for intranasal formulations [64]. Hydrophobic interactions underlie the LCST behavior of pNIPAAm and poloxamer systems. Crosslinking chemistry governs wet tissue adhesion — the core challenge in nasal dressings Nasal mucosa presents a continuously renewed, mucus-coated, shear-stressed surface on which conventional pressure-sensitive adhesives fail. Effective wet tissue adhesion demands rapid interfacial water displacement and the formation of reversible bonds with mucosal components. The four main chemistries contribute differently: Catechol/dopa chemistry (inspired by mussel foot proteins) offers multi-mode adhesion: catechols form covalent bonds with primary amines (via quinone intermediates), coordinate with metal ions, and engage in π–π and hydrogen-bonding interactions with aromatic/amide residues of mucin [65]. Dopamine-functionalized HA or chitosan achieves tissue adhesion strengths of 20–100 kPa, an order of magnitude above unmodified polysaccharides. Boronic ester–diol chemistry provides selective, reversible adhesion to sialic-acid- and catechol-rich mucosal glycoproteins; its reversibility facilitates atraumatic removal, a decisive advantage in the nasal cavity where conventional packing removal causes re-bleeding in up to 20% of cases [66]. Aldehyde–amine (Schiff base) chemistry forms covalent tissue-to-hydrogel bonds but is irreversible and may cause mucosal irritation at high aldehyde loadings. Zwitterionic hydration layers resist non-specific fouling while enabling secondary bonds (hydrogen bonding, electrostatic) with the mucus layer, achieving “hydration lubrication” that reduces friction during removal and minimizes secondary trauma (see Section “Patient comfort enhancement: rheology, mechanical matching, and tribology”) [58]. For nasal applications, a hybrid strategy—combining catechol or boronic ester wet-adhesion motifs with zwitterionic or chitosan antifouling/antibacterial backbones—represents the current state of the art. Table 1 summarizes representative systems. Stimuli-responsive hydrogels: reaction pathways and kinetics Stimuli-responsive hydrogels translate pathological cues into therapeutic action through well-defined chemical reactions whose kinetics ultimately determine clinical performance. This section moves beyond phenomenological description to analyze the underlying reaction pathways, rate constants, and molecular conformational changes, with particular attention to how these parameters match the specific nasal microenvironment quantified in Section “Physicochemical profile of the nasal wound microenvironment”. pH-responsive hydrogels pH-responsive hydrogels form three-dimensional networks through attractive electrostatic interactions between oppositely charged polymer chains, or through protonation/deprotonation of ionizable groups that modulate swelling behavior [76, 77]. The key design parameter is the pKa of the ionizable group, which must be matched to the pH window of the target tissue: for a nasal wound environment with pH 6.3–7.3, polymer networks with pKa values in the same range undergo the largest swelling transitions and thus the most pronounced drug-release modulation [78]. Mechanistically, weakly acidic groups such as carboxylic acids (pKa ≈ 4–5 in polyacrylic acid; 4.7 in polymethacrylic acid) are fully deprotonated at nasal pH, exposing anionic –COO⁻ groups whose electrostatic repulsion drives chain extension and gel swelling. Conversely, in the acidic inflammatory phase (pH < 5.5), protonation collapses these charges, inducing gel contraction and accelerated release of encapsulated alkaline cargo such as antibiotics. Weakly basic groups (amines, pKa ≈ 7–9) show the inverse behavior: protonated and swollen at low pH, deprotonated and collapsed at neutral pH. Chitosan (amine pKa ≈ 6.5) is a particularly suitable backbone for nasal applications because its ionization state transitions precisely within the physiological pH window, generating pH-tuned mucoadhesion and drug release [45, 78]. For example, Sun et al. developed an ion-sensitive in situ gel using deacetylated gellan gum as the matrix, where divalent cations in nasal fluid trigger electrostatic crosslinking and a sol–gel transition that significantly prolongs mucosal residence time [79]. A more chemically sophisticated example is the pH-responsive liposome–hydrogel composite of Yang et al., which embeds acylhydrazone-modified dexamethasone-loaded liposomes within a poly(hydroxyethylacrylamide-co-diethylacrylamide) (HEAA/DEAA) matrix [67]. The acylhydrazone linkage is hydrolytically stable at physiological pH 7.4 but cleaves rapidly in acidic microenvironments (half-life ~ 4 h at pH 5.0), providing pH-triggered drug release precisely aligned with inflammatory acidification. In vivo, the composite achieved superior mucosal regeneration and collagen organization compared with clinical hyaluronic acid packing in a rabbit nasal septal injury model. Nakamura et al. also showed that mucoadhesive pH-sensitive copolymers can regulate budesonide uptake and release in nasal delivery, supporting pH-dependent swelling and mucosal retention as useful design principles [68]. Critical evaluation: While pH-responsive hydrogels elegantly exploit the acidic shift of the wound microenvironment, their clinical translatability faces three challenges. First, the physiological pH buffering capacity of nasal secretions (bicarbonate, phosphate) can dampen the local pH swing actually experienced at the hydrogel–tissue interface, reducing responsiveness in vivo compared with in vitro predictions. Second, the ionic strength of nasal fluid (≈ 150 mM NaCl) screens electrostatic interactions and can destabilize polyelectrolyte-complex hydrogels, a recognized failure mode of alginate- and chitosan/HA-based systems [64]. Third, the pH window between healthy and pathological states (∆pH ≈ 0.5–1 unit) is narrower than in tumor microenvironments (∆pH ≈ 1.5–2), requiring polymer designs with pKa values tuned with high precision. ROS-responsive hydrogels Reactive oxygen species (ROS) accumulate to pathological levels in nasal wounds—intracellular H₂O₂ concentrations of ≈ 100–600 µM versus a healthy baseline of 1–100 nM; superoxide and hydroxyl radical concentrations in inflammatory foci that exceed healthy levels by 2–3 orders of magnitude [21, 22]. ROS-responsive hydrogels exploit this concentration gradient through chemical motifs that undergo selective oxidation, cleavage, or rearrangement upon encountering ROS. Reaction pathways of common ROS-responsive motifs Three chemical motifs dominate the field, each with distinct kinetics and ROS specificity. Thioketals and thioacetals undergo oxidative cleavage via a two-step mechanism: initial oxidation of thioether sulfur to sulfoxide/sulfone, followed by nucleophilic substitution that releases the parent carbonyl and two thiol products. The overall reaction follows pseudo-first-order kinetics in thioketal concentration. Crucially, the rate is strongly dependent on both ROS species and aromatic substituent. With H₂O₂, benzylidene thioketals exhibit second-order rate constants of k = 8.0 × 10⁻³ M⁻¹·h⁻¹ (electron-poor p-Cl) to 4.3 × 10⁻² M⁻¹·h⁻¹ (electron-rich p-OMe), yielding a Hammett ρ ≈ − 1.42 that confirms rate-limiting electrophilic attack on sulfur [80]. These rates translate to practical half-lives of days-to-weeks at H₂O₂ concentrations of 100 µM. With hypochlorite (HOCl/OCl⁻)—a neutrophil-derived ROS abundant in acute infection—aryl thioether oxidation is approximately 10⁸-fold faster than with H₂O₂, implying that HOCl, rather than H₂O₂, may be the dominant physiological trigger in some inflammatory contexts [81]. Boronic esters cleave via a different pathway: H₂O₂ adds to the empty p-orbital of boron to form a tetrahedral peroxoboronate intermediate, which rearranges to insert the oxygen between boron and the aromatic ring, ultimately hydrolyzing to release the corresponding phenol and boric acid. This mechanism is remarkably selective for H₂O₂ (over other ROS). Arylboronic acids and their esters show second-order rate constants with H₂O₂ of 0.1–1.8 M⁻¹·s⁻¹ under physiological conditions [82, 83]. For a representative tetraphenylethylene-based diboronic crosslinker (TSPBA) crosslinked with PVA, a H₂O₂ concentration of 1 mM was sufficient to completely release encapsulated rapamycin within 4 days, whereas < 20% release occurred without H₂O₂ over the same period [55]. Thioethers oxidize to sulfoxides with rate constants of 2.5 × 10⁻³ M⁻¹·s⁻¹ (H₂O₂, pH 7.4) to 3.7 × 10⁸ M⁻¹·s⁻¹ (HOCl)—a span of 11 orders of magnitude depending on ROS species [81]. This massive kinetic difference means that in the nasal cavity, where neutrophil-derived HOCl can be generated during acute infection, a thioether-based hydrogel may respond almost instantaneously; in low-grade chronic inflammation dominated by H₂O₂, the same hydrogel may respond only over hours to days. Comparative summary: For nasal wound applications, boronic ester chemistry offers the best compromise—H₂O₂-specific, operating at physiologically relevant concentrations (sub-millimolar), with cleavage kinetics (hours) that match the inflammatory window. Thioketals are slower but useful for sustained scavenging over weeks. Thioether-based systems may be ideal for acute infection responses via HOCl. Boralactones and borinic acids—newer chemistries with 10⁴-fold higher H₂O₂ reactivity than standard PBA (second-order rate constant 1.9 × 10⁴ M⁻¹·s⁻¹)—offer opportunities for ultra-sensitive, rapid-response hydrogels, but clinical data remain limited [82, 84]. Representative ROS-responsive nasal hydrogels Zhao et al. constructed a TSPBA-crosslinked PVA hydrogel for the treatment of allergic rhinitis, in which the rapid formation of boronic ester bonds between the phenylboronic acid crosslinker and PVA hydroxyls occurs within seconds of contact [61]. Within the inflammatory foci of allergic rhinitis, where H₂O₂ concentrations reach 100–500 µM, boronic ester cleavage proceeds with a half-life of ~ 4–8 h, enabling sustained ipratropium bromide release over 24 h and effective downregulation of MUC5AC and inflammatory cytokines. In vitro and in vivo experiments confirmed that this ROS-triggered degradation significantly prolonged drug retention on the nasal mucosa while effectively downregulating inflammatory factor expression and reducing mucus secretion. Huang et al. constructed an injectable ROS-responsive HAC hydrogel based on dopamine-functionalized hyaluronic acid, 4-formylphenylboronic acid, and carboxymethyl chitosan via combined boronic ester and imine bonds [62]. Although this system was originally developed for bone-defect repair rather than nasal mucosal wounds, the dual dynamic covalent network is directly relevant to nasal hydrogel design because it couples ROS-responsive degradation, anti-inflammatory drug release, self-healing behavior, and wet-tissue adhesion. In vitro and in vivo analyses showed intracellular ROS scavenging, reduced pro-inflammatory cytokine secretion, and improved tissue repair outcomes, supporting its use as a chemically verified design analogue for inflammation-responsive nasal hydrogel systems. Critical evaluation: ROS-responsive hydrogels promise elegant feedback control but face several translational limitations. First, boronic ester hydrogels are inherently unstable under physiological conditions even without ROS: pure PBA/diol systems degrade in PBS within hours-to-days, complicating long-term drug delivery [55]. Incorporating multivalent PBAs (e.g., TSPBA) or benzoxaborole variants with lower pKa improves stability. Second, degradation byproducts (phenylboronic acids, boric acid) have known but modest cytotoxicity at high concentrations; local accumulation in the enclosed nasal cavity has not been rigorously studied. Third, off-target ROS consumption may compromise normal physiological redox signaling—a concern particularly relevant at the mucociliary interface where low-level ROS signaling regulates ciliary beating. Temperature-responsive hydrogels Temperature-responsive hydrogels undergo reversible sol–gel transitions in response to environmental temperature changes [85, 86]. Their core functionality originates from temperature-dependent conformational changes of polymer chains such as poly(N-isopropylacrylamide, pNIPAAm) or poloxamers in aqueous solution. Below the lower critical solution temperature (LCST), polymer chains remain extended due to strong hydrogen bonding with water molecules, yielding a free-flowing sol; above the LCST, hydrogen bonds are disrupted, hydrophobic interactions dominate, chains collapse, and a three-dimensional network forms [87]. The critical pNIPAAm–nasal temperature mismatch A frequently overlooked but design-critical consideration is the mismatch between the LCST of pNIPAAm (≈ 32 °C) and the physiological nasal temperature (30–34 °C, anatomically heterogeneous) [27]. This places the nasal cavity within the transition zone of pNIPAAm, not above it. The practical consequences are significant: (i)Anatomical heterogeneity of gelation: The anterior nasal vestibule is cooler (30–31 °C during normal breathing) while the posterior nasopharynx approaches core temperature (≈ 34 °C). A pNIPAAm system applied as a spray may gel incompletely in the anterior cavity while gelling immediately posteriorly, resulting in uneven coverage. Anatomical heterogeneity of gelation: The anterior nasal vestibule is cooler (30–31 °C during normal breathing) while the posterior nasopharynx approaches core temperature (≈ 34 °C). A pNIPAAm system applied as a spray may gel incompletely in the anterior cavity while gelling immediately posteriorly, resulting in uneven coverage. (ii)Respiration-induced temperature fluctuations: The nasal cavity experiences cyclic temperature changes with breathing, particularly during mouth breathing or cold-air exposure. These fluctuations can induce partial sol–gel cycling and compromise structural integrity of pure pNIPAAm hydrogels. Respiration-induced temperature fluctuations: The nasal cavity experiences cyclic temperature changes with breathing, particularly during mouth breathing or cold-air exposure. These fluctuations can induce partial sol–gel cycling and compromise structural integrity of pure pNIPAAm hydrogels. (iii)Rational design solutions: The LCST can be tuned by copolymerization with hydrophilic monomers (e.g., acrylamide, HEAA) that raise the LCST, or with hydrophobic monomers (e.g., butyl methacrylate) that lower it. For nasal applications, targeting an LCST of 28–30 °C ensures gelation across the entire cavity and preserves the gel state under mild temperature fluctuations [88]. Alternatively, dual-responsive systems (e.g., pNIPAAm-co-AAc) add pH responsiveness as a redundant trigger. Poloxamer-based systems (e.g., Pluronic F127 with a gelation temperature tunable from 20 to 40 °C by concentration) offer similar versatility and are more biocompatible than pure pNIPAAm. Rational design solutions: The LCST can be tuned by copolymerization with hydrophilic monomers (e.g., acrylamide, HEAA) that raise the LCST, or with hydrophobic monomers (e.g., butyl methacrylate) that lower it. For nasal applications, targeting an LCST of 28–30 °C ensures gelation across the entire cavity and preserves the gel state under mild temperature fluctuations [88]. Alternatively, dual-responsive systems (e.g., pNIPAAm-co-AAc) add pH responsiveness as a redundant trigger. Poloxamer-based systems (e.g., Pluronic F127 with a gelation temperature tunable from 20 to 40 °C by concentration) offer similar versatility and are more biocompatible than pure pNIPAAm. Representative systems Schilling et al. leveraged the intelligent phase transition of pNIPAAm-based thermoresponsive hydrogels combined with the controlled-release properties of PLGA microspheres to design a long-acting corticosteroid delivery system for the paranasal sinuses [71]. The system remains a flowable sol at room temperature, enabling injection into the sinus cavity; upon exposure to body temperature, sol–gel transition occurs within seconds, forming a semi-solid depot that adheres to the sinus mucosa. The embedded PLGA microspheres further modulate release through diffusion and bulk erosion, achieving corticosteroid release over weeks to months. Mechanically, the system showed a storage modulus of 0.5–3 kPa post-gelation, suitable for maintaining depot integrity against MCC shear while avoiding mucosal compression injury. A follow-up freeze-dried pNIPAAm/PEG thermoresponsive system further improved ready-to-use storage stability while maintaining microsphere-based release and mucosal residence for sinus delivery [72]. Wu et al. also reported a quaternized chitosan/PEG thermosensitive nasal gel that forms in situ and prolongs retention and release of hydrophilic macromolecules, illustrating the value of absorption-enhancing thermogels [73]. Yathavan et al. developed a silk-elastin-like polymer (SELP)/silver-nanoparticle composite hydrogel for anti-biofilm therapy in chronic rhinosinusitis [51]. SELPs exhibit β-sheet-driven thermoresponsive assembly with tunable transition temperatures of 25–37 °C, offering a more mechanically robust alternative to pNIPAAm (G′ of 1–10 kPa post-gelation). The system achieved sustained silver nanoparticle release with antibacterial efficacy against S. aureus and P. aeruginosa biofilms comparable to ciprofloxacin, while the incorporated HA component down-regulated IL-6 and IL-8 release from LPS-stimulated macrophages. Critical evaluation Thermoresponsive systems offer outstanding injectability but several limitations deserve emphasis. Pure pNIPAAm is non-biodegradable and its residual monomer is cytotoxic; clinically, pNIPAAm hydrogels are usually copolymerized with biodegradable segments or used as temporary scaffolds. Poloxamer systems, while biocompatible, have relatively low mechanical strength (typically < 1 kPa) that may prove insufficient for hemostasis under arterial pressure. All thermoresponsive systems also face the challenge of drug burst release during the sol state prior to gelation—a particular concern in the nasal cavity where the pre-gelled liquid can be cleared by MCC before gelation is complete. Other stimuli-responsive hydrogels Beyond the three chemistries above, several additional stimulus-response modalities merit consideration for nasal applications. Enzyme-responsive hydrogels Enzymes overexpressed at wound sites—most notably matrix metalloproteinases (MMPs, particularly MMP-9 in chronic inflammation) and neutrophil elastase—enable selective drug release triggered by disease activity [89]. Hydrogels crosslinked with MMP-cleavable peptide sequences (e.g., GPQG↓IAGQ) or containing gelatin substrates degrade in direct proportion to local protease activity. For nasal wounds, lysozyme—present at high concentration in nasal secretions—is particularly relevant: chitosan and its derivatives are cleaved by lysozyme, providing an intrinsic, site-specific degradation route that simultaneously releases antimicrobial chitooligosaccharides [30, 46]. Ribeiro et al. developed an MMP-responsive gelatin methacryloyl hydrogel loaded with chlorhexidine-laden nanotubes, providing on-demand antibiotic release upon elevated MMP-1/2/8/9 concentrations [89]. While not yet applied to nasal surgery, such systems hold translational promise for chronic rhinosinusitis with persistent neutrophilic inflammation. Ultrasound-responsive hydrogels Ultrasound provides non-invasive, spatiotemporally precise external triggering through mechanical (cavitation) or thermal effects. Ultrasound-responsive hydrogels have been engineered to incorporate gas-generating microbubbles or piezoelectric nanoparticles that convert acoustic energy into local pressure waves or voltage, triggering network disruption and cargo release [90]. For nasal wounds, the accessibility of the cavity to low-intensity focused ultrasound via external transducers offers a practical delivery modality. The piezoelectric amino-modified barium titanate/gelatin-chondroitin sulfate nanocomposite hydrogel reported for bone defects [91] represents a class of materials directly translatable to nasal applications where ultrasound-triggered drug release could complement postoperative monitoring. Light-responsive (particularly near-infrared) hydrogels Near-infrared (NIR) light (700–1100 nm) penetrates soft tissue with minimal scattering and is well-suited to the superficial location of the nasal mucosa. NIR-responsive hydrogels typically incorporate photothermal agents (polydopamine, MXene, black phosphorus, gold nanoparticles) that convert NIR to local heat, triggering phase transitions, crosslink rupture, or drug release [92, 93]. Chen et al. engineered a dopamine–HA hydrogel encapsulating MXene-loaded nanofibers that released VEGF upon NIR irradiation, driving M2 macrophage polarization and accelerating wound healing [92]. Zhai et al. developed a carboxymethyl chitosan/oxidized sodium alginate hydrogel with puerarin-loaded mesoporous polydopamine nanoparticles, achieving NIR-triggered low-temperature photothermal antimicrobial therapy [94]. For nasal surgical beds, NIR activation offers precise, minimally-invasive external control over drug delivery. Electro- and magneto-responsive hydrogels Conductive hydrogels incorporating polypyrrole, PEDOT: PSS, or graphene enable electrical-field-triggered drug release and have been used in skeletal muscle regeneration to deliver external electrical stimulation [95]. Magnetic hydrogels containing iron-oxide nanoparticles permit remote manipulation and localized hyperthermia under external magnetic fields [96]. These modalities are at an earlier translational stage than pH/ROS/thermal systems but offer interesting possibilities for combined drug delivery and neuromodulation in complex sinonasal procedures. Glucose- and dual/multi-stimuli systems Glucose-responsive systems, typically based on PBA–diol chemistry, are important in diabetic wound contexts where hyperglycemia impairs healing. While less directly relevant to non-diabetic nasal wounds, dual ROS/glucose-responsive hydrogels have been developed for diabetic complications that may involve the sinonasal region. More broadly, multi-stimuli-responsive hydrogels that integrate pH + ROS + enzyme responsiveness represent the current frontier, enabling sequential drug release tailored to the inflammation-proliferation-remodeling progression of wound healing [89, 97]. Figure 2 summarizes the chemical pathways and kinetic parameters of the major stimuli-responsive motifs discussed in this section, illustrating how pH, ROS, temperature, and enzyme cues are transduced into hydrogel degradation or cargo release. Chemical pathways and molecular responses of representative stimuli-responsive motifs in nasal hydrogels. pH-responsive networks regulate swelling, degradation, and cargo release through pKa-dependent ionization of carboxyl- and amine-bearing groups, with the direction and magnitude of the response depending on the dominant ionizable moieties and polymer architecture. ROS-responsive motifs, including boronic esters, borinic acids, thioethers, and thioketal/thioacetal linkages, undergo chemically distinct oxidation or cleavage pathways that convert inflammatory oxidative cues into network relaxation, degradation, and therapeutic release. Thermoresponsive pNIPAAm-based systems rely on LCST-associated chain dehydration and hydrophobic association, but their transition near 32 °C must be carefully matched to the anatomically heterogeneous nasal temperature range. Enzyme- and photothermal-responsive hydrogels further enable MMP-mediated peptide cleavage or NIR-triggered local heating for on-demand structural transition and cargo release. Rate constants are representative literature-derived values and are system- and condition-dependent Applications of functional hydrogels in nasal wound healing Lessons from tissue engineering in other organs: a brief perspective Functional hydrogels have demonstrated substantial promise in diverse regenerative contexts including bone defects, diabetic chronic wounds, and skeletal muscle reconstruction, with several design principles transferable to the nasal cavity: extracellular-matrix-mimicking viscoelasticity, dynamic crosslinking for cellular remodeling, multi-growth-factor co-delivery, and immune microenvironment modulation [98–100]. However, nasal mucosa represents a fundamentally distinct tissue—characterized by a highly vascularized, ciliated pseudostratified epithelium continuously exposed to airflow, a shear-thinning mucus layer undergoing active clearance, and a slightly acidic, microbially-colonized microenvironment (Section “Physicochemical profile of the nasal wound microenvironment”). These features preclude direct translation of bone- or muscle-regenerating hydrogels to the nasal cavity; rather, they must inform the selective adaptation of design principles. Key transferable insights include: (i) dynamic covalent networks enable cell migration and scaffold remodeling under the dynamic mucosal microenvironment [101]; (ii) matrix viscoelasticity—rather than stiffness alone—regulates both epithelial migration and macrophage polarization [102]; (iii) sequential growth-factor release aligned with the inflammation–proliferation–remodeling timeline accelerates healing [103]; and (iv) skin regeneration hydrogels, with their similar epithelial-barrier regeneration requirements, are particularly relevant analogues for nasal mucosal repair [104]. Zwitterionic hydrogels, widely explored in diabetic and chronic cutaneous wounds for their antifouling and antimicrobial properties, also provide design inspiration for nasal applications where mucin fouling is a major failure mode [105, 106]. The remainder of this review focuses exclusively on nasal-specific applications, building directly upon the physicochemical design framework of Sections “Physicochemical profile of the nasal wound microenvironment”–“Stimuli-responsive hydrogels: reaction pathways and kinetics”. Specific applications of functional hydrogels in nasal wound repair Nasal wound healing presents a unique combination of challenges: narrow irregular anatomy, continuous mucus clearance, high propensity for inflammation and infection, and vulnerability of ciliary function to chemical and mechanical insult (Section “Physicochemical profile of the nasal wound microenvironment”). Functional hydrogels—through dynamic wet-tissue adhesion (Section “Crosslinking chemistry governs wet tissue adhesion — the core challenge in nasal dressings”), injectable in situ gelation, stimuli-responsiveness matched to nasal pH/ROS/temperature (Section “Stimuli-responsive hydrogels: reaction pathways and kinetics”), and modulation of the immune microenvironment—are uniquely suited to this setting [107, 108]. The following subsections detail their core functions: rapid hemostasis, anti-adhesion, promotion of wound healing, patient comfort enhancement, anti-inflammatory/antimicrobial actions, and—newly addressed—applications in post-radiotherapy nasopharyngeal carcinoma care.The mechanism of action of functional hydrogels in the cascading reaction of nasal wound healing is shown in Fig. 3. Mechanisms of functional hydrogels across the nasal wound-healing cascade. Functional hydrogels contribute to nasal wound repair through stage-dependent and mechanism-specific actions, including rapid hemostasis, anti-adhesion, wound-healing promotion, patient comfort enhancement, anti-inflammatory/antimicrobial modulation, and post-radiotherapy NPC-associated mucosal injury care. These effects arise from material properties such as in situ gelation, conformal wet-tissue adhesion, temporary physical separation of injured mucosal surfaces, ECM-mimetic hydration, controlled bioactive release, ROS scavenging, viscoelastic matching, and hydration lubrication. Representative functions are illustrated; individual hydrogel systems may possess only selected activities depending on polymer matrix, crosslinking chemistry, degradation behavior, and therapeutic cargo Hemostasis Rapid and effective hemostasis is the primary objective in the management of nasal wounds. Uncontrolled hemorrhage can lead to hematoma formation, increase infection risk, and impede the migration and adhesion of epithelial cells, thereby delaying healing and potentially leading to scar formation. Functional hydrogels achieve efficient hemostasis through a dual mechanism combining physical sealing and bioactive activation. Physically, the pre-gel solution can flow into and conform to the irregular wound bed, subsequently undergoing rapid sol–gel transition triggered by body temperature, ionic environment, or self-assembly, forming a three-dimensional network that mechanically covers and compresses damaged vessels. RADA16, a self-assembling 16-residue peptide (Ac-(RADA)₄-CONH₂), exemplifies this class: upon contact with nasal tissue fluid at physiological pH, the alternating hydrophobic/hydrophilic/charged residues drive β-sheet assembly into a nanofibrous three-dimensional network within seconds, achieving hemostasis without reliance on the coagulation cascade [52, 109]. In a prospective clinical series of patients with refractory epistaxis, RADA16 hydrogel significantly reduced the Epistaxis Severity Score (ESS) without serious adverse events [109]. Lee and Ananda systematically evaluated the RADA16 self-assembling peptide hydrogel for postoperative hemostasis, synechiae prevention, and wound healing promotion in a sheep endoscopic nasal surgery model [52]. Intraoperative hemostasis time was improved for RADA16 (139.7 ± 56.2 s) and gelatin-thrombin (145.4 ± 58.1 s) compared with untreated controls (224.0 ± 69.9 s; p < 0.0001 for both). More importantly, RADA16 demonstrated significant advantages in synechiae reduction: 91–92% reduction at 2 weeks and 100% adhesion-free rate at 6 weeks, compared with 35–50% adhesion incidence in the gelatin-thrombin and control groups. Histopathological analysis showed reduced submucosal fibrosis and abnormal angiogenesis with preserved mucosal structure regeneration. Alternative hemostatic approaches exploit the intrinsic bioactivity of the hydrogel matrix. Chitosan-based hydrogels, with their cationic amine groups, attract negatively charged erythrocytes and platelets, accelerating clot formation independent of the intrinsic coagulation pathway [45, 46]. PEG-based thermoresponsive hydrogels enable controlled co-delivery of thrombin, accelerating fibrin formation directly at the bleeding site [110]. Through molecular design, cell-adhesive peptides (e.g., RGD) can be incorporated to actively guide platelet aggregation, while protease-cleavable crosslinkers link degradation kinetics to local healing progression [111]. Critical evaluation Several limitations deserve recognition. RADA16-based systems, while superior in adhesion prevention, achieve relatively modest mechanical strength (G′ ≈ 0.1–0.5 kPa), which may be insufficient for arterial-pressure epistaxis without adjunctive mechanical support. Chitosan-based systems rely on the acidic pH optimum for solubilization, which complicates delivery at the near-neutral nasal pH; quaternized derivatives address this limitation but may alter biocompatibility. Importantly, purely physical hemostats (RADA16) lack anti-infective action, so combination strategies incorporating silver nanoparticles or antimicrobial peptides are being explored for contaminated wound beds. Anti-adhesion Pathological adhesion between mucosal tissues following nasal and sinus surgery—driven by excessive fibrin deposition and abnormal fibroblast-to-myofibroblast transition—can obstruct nasal airflow and sinus drainage, potentially causing chronic sinusitis or hyposmia [112–114]. Effective adhesion prevention is thus crucial for long-term surgical success. Chitosan-based hydrogels achieve adhesion prevention through a combination of physical barrier function and intrinsic antifibrotic activity [115]. Medina et al. systematically evaluated a sprayable chitosan/dextran aldehyde hydrogel in two animal models [116]. In vitro, the hydrogel significantly inhibited migration and proliferation of human nasal-polyp-derived fibroblasts. In a rabbit cecum-sidewall adhesion model, application reduced total adhesion score by 94% (p < 0.001); in a sheep sinus surgery model, adhesion incidence decreased from 80% to 10% (p = 0.003). The hydrogel exhibited good biocompatibility, sprayability, intraoperative visibility, and persistence at the wound site during the critical healing period. Consistently, Athanasiadis et al. showed in a sheep ESS model that a chitosan/dextran derivative gel reduced adhesion formation and improved microscopic mucosal repair, including re-epithelialization and reciliation [69]. Lee and Ananda’s sheep endoscopic nasal surgery model (Section “Hemostasis”) demonstrated superior synechiae prevention by RADA16 versus gelatin-thrombin and untreated controls [52]. The mechanistic basis extends beyond passive physical barrier: histopathology showed reduced submucosal fibrosis and pathological angiogenesis at 6 weeks, suggesting that RADA16 modulates key cellular drivers of adhesion formation—possibly through macrophage polarization toward M2 phenotype and inhibition of fibroblast-to-myofibroblast transition (Section “Cell–material interactions at the hydrogel–mucosa interface”). Recent clinical trials (summarized in Table 2) further support the anti-adhesion efficacy of peptide- and polysaccharide-based hydrogels. The randomized controlled trial by Hur et al. directly compared a RADA16 peptide hydrogel to a chitosan-based polymer in a bilateral ESS cohort, showing significant reductions in debridement-associated pain and comparable healing outcomes [117]. A separate randomized trial evaluating Chitogel versus PureRegen Gel after ESS also confirmed clinical non-inferiority of both products for synechiae prevention [118]. The ongoing NCT05898074 trial at Indiana University is specifically evaluating RADA16 (PuraGel) in endoscopic skull-base surgery, a more demanding anatomical context [54]. Padalhin et al. further evaluated sodium hyaluronate-based freeze-dried composite hydrogels for the prevention of postoperative nasal adhesions, providing additional support for HA-based hydrogel barriers in sinonasal wound management [143]. Table 2Recent and ongoing clinical trials of functional hydrogels for nasal wound healingIdentifier / ReferenceInterventionIndication / SettingDesignKey OutcomesStatusShi et al., 2013 [49]Cross-linked hyaluronan hydrogelPost-ESS wound healingProspective RCT, bilateral ESS, 55 patientsSignificantly promoted re-epithelialization at 2/4/8 weeks; reduced synechiae, edema, crusting, mucopurulent drainage (all p ≤ 0.0002)PublishedBerlucchi et al. [48]MeroGel® (esterified HA, HYAFF®)Post-FESS wound healingRCT vs. PVA spongeComplete re-epithelialization 84.4% vs. 58.9% at 4 weeks (p = 0.035); adhesion at 12 weeks 4.6% vs. 29.7% (p < 0.001)PublishedYamashita et al. [75]CG chitosan-gluconate hydrogelPost-ESS packingPilot clinical (3 patients) + animalTrends toward better epistaxis and pain scores vs. calcium alginatePublished (2025)NCT04970966 [117]PuraSinus (RADA16) vs. PosiSep XPost-ESS debridement comfortRandomized, double-blind, parallelSignificantly reduced debridement pain with PuraSinusCompletedHur et al., 2024 / PMID 38,932,659 [117]RADA16 peptide vs. chitosan polymerBilateral ESS debridementProspective multicenter RCTReduced pain during debridement with RADA16Published (2024)Cavada et al. [118]Chitogel vs. PureRegen GelPost-ESSDouble-blinded RCTComparable synechiae prevention outcomesPublished (2025)NCT05898074 [54]PuraGel (RADA16) vs. silastic splintEndoscopic skull-base surgeryRandomized, single-maskedNasoseptal flap harvest site recovery (ongoing)RecruitingNCT06551766 [131]Photosensitive hydrogel vs. conventional sutureIntranasal endoscopic dacryocystorhinostomy; lacrimal sac flap–nasal mucoperiosteal flap anastomosisProspective randomized controlled single-center clinical study; 20 subjects; 1:1 allocationEvaluates safety and efficacy of photosensitive hydrogel for suture-free flap anastomosis, wet-tissue adhesion, wound closure, and postoperative recoveryRecruitingPadalhin et al., 2024 / PMID 39,116,908 [143]Sodium hyaluronate-based freeze-dried composite hydrogels (SH-COL1 and SH-CMC-COL1)Prevention of postoperative nasal adhesionsPreclinical evaluation against commonly used biodegradable nasal-surgery materialsAssessed bleeding time, wound healing, and fibrous tissue formation; supported SH-based composite hydrogels as short- and long-term nasal adhesion barriersPublished Recent and ongoing clinical trials of functional hydrogels for nasal wound healing Critical evaluation Current anti-adhesion hydrogels face several trade-offs. Rapidly degrading systems (≤ 2 weeks in vivo) may fail to maintain separation through the critical fibroblast-proliferation window (typically 2–4 weeks postoperatively), whereas slowly degrading systems risk impairing mucociliary clearance and promoting biofilm formation. Chitosan-based gels carry theoretical shellfish-allergy concerns. Head-to-head comparative efficacy data among the major clinical products (RADA16, Chitogel, PureRegen Gel, MeroGel) remain limited, complicating evidence-based product selection. Promotion of wound healing The nasal mucosa, as the first line of respiratory defense, supports critical physiological processes including immune defense, air conditioning, filtration, and olfactory perception. Impaired healing can result in chronic pain, recurrent bleeding, permanent ciliary dysfunction, and even olfactory disorders, severely impacting quality of life [119–121]. Functional hydrogels promote healing through multi-dimensional mechanisms: biomimetic viscoelastic scaffolding, sequential bioactive factor release, immune microenvironment modulation, and active support of mucociliary regeneration [122]. Yamashita et al. developed an injectable chitosan-gluconic acid copolymer hydrogel (CG hydrogel) that is stable at physiological pH and is slowly degraded in vivo by lysozyme, yielding chitooligosaccharide degradation products that actively recruit neutrophils; these in turn secrete pro-healing cytokines that accelerate repair [75]. In a rat full-thickness skin defect model, the time required for 50% wound closure was significantly shorter with CG hydrogel than with a commercial chitosan/chitin dry dressing, underscoring the superiority of the “moist wound healing” strategy. Preliminary clinical data in three post-ESS patients showed trends toward better outcomes versus calcium alginate dressings in terms of postoperative epistaxis and pain scores. Drug-loaded hydrogels for nasal wound healing exploit the hydrogel matrix as a sustained-release reservoir for growth factors, antibiotics, and anti-inflammatory agents—a critical capability given the challenge of maintaining therapeutic drug concentrations against continuous mucociliary clearance. Examples with direct nasal relevance include: (i) Yang et al.‘s pH-responsive liposome–hydrogel composite delivering dexamethasone for nasal mucosal regeneration, with sustained release over 14 days in a rabbit septal injury model [67]; (ii) Schilling et al.‘s pNIPAAm-PLGA microsphere system for long-acting corticosteroid delivery to the paranasal sinuses [71]; (iii) Jalessi et al.‘s tyramine-PVA microparticles co-releasing ciprofloxacin and dexamethasone in a rabbit maxillary sinus model [70]; and (iv) thermoresponsive chitosan-β-glycerophosphate systems delivering miR-146a for allergic rhinitis [74]. These examples demonstrate that hydrogel matrices can be engineered to deliver virtually any drug class relevant to nasal wound healing—antibiotics, corticosteroids, growth factors, nucleic acids—with release kinetics tunable over hours to months. Berlucchi et al. evaluated MeroGel® (an esterified hyaluronic acid hydrogel, HYAFF®) as postoperative packing following FESS in a randomized controlled study [48]. Rigorous endoscopic evaluation at 2, 4, and 12 weeks confirmed significant promotion of wound healing: complete re-epithelialization at 4 weeks was achieved in 84.4% of MeroGel-treated sites versus 58.9% of controls (p = 0.035); absence of granulation tissue in 36.4% versus 10.5% (p < 0.001); and adhesion incidence at 12 weeks of 4.6% versus 29.7% (p < 0.001). The material’s degradation into a high-viscosity gel provides sustained physical separation and biological support, mimicking the ECM and actively guiding orderly mucosal regeneration. Shi et al. further validated a new absorbable cross-linked hyaluronan hydrogel in a prospective bilateral ESS trial, demonstrating significant promotion of re-epithelialization at 2, 4, and 8 weeks postoperatively and statistically significant reduction of synechiae, edema, crusting, and mucopurulent drainage (all p ≤ 0.0002) [49]. Patient comfort enhancement: rheology, mechanical matching, and tribology Patient comfort during nasal wound healing is as important as therapeutic efficacy, but the materials-science basis for comfort has often been reduced to clinical terminology such as “softness” or “non-adherence.” A rigorous translation requires framing comfort in terms of three quantitative physical properties: rheology, mechanical matching, and tribology [117, 118]. Rheology and mechanical matching The storage modulus G′ and loss modulus G′′ of the hydrogel should be matched to the Young’s modulus of the target nasal mucosa (≈ 1–10 kPa) to minimize interfacial stress concentration. Excessively stiff materials (G′ >>10 kPa) transmit pressure waves to sensitive subepithelial nociceptors, generating pain; excessively soft materials (G′ <0.1 kPa) fail to maintain structural integrity and are rapidly cleared by MCC. Thermoresponsive chitosan/β-glycerophosphate and pNIPAAm-based systems achieve G′ values of 0.5–3 kPa after in situ gelation, within the mucosal range, and can be further tuned by composition (e.g., HA or collagen incorporation) [122]. The ability to apply the material in liquid form and have it gel in situ is itself a major comfort advantage, avoiding the mechanical trauma of forcing solid packing into narrow, irregular passages. Tribology and hydration lubrication: The coefficient of friction at the hydrogel–tissue interface critically determines removal trauma. Hydrophilic polymer brushes or hydration layers on the hydrogel surface generate a strongly bound water film (hydration lubrication), dramatically lowering friction. Zwitterionic polymers (polycarboxybetaine, polysulfobetaine) excel at this mechanism because their charge-balanced hydration shells approach the friction coefficient of natural synovial interfaces [105, 106]. Liao et al. engineered a hydration-lubrication coating for nasogastric tube intubation, which reduced mucosal injury and inflammatory responses through suppression of the NF-κB pathway, providing a useful tribological design analogy for nasal hydrogel comfort [123]. At the molecular level, such comfort-by-lubrication coincides mechanistically with reduced inflammation, supporting the translation of surface-hydration strategies into atraumatic nasal hydrogel design. Mechanical compatibility with the olfactory mucosa (Section “Olfactory epithelium: a site of heightened sensitivity”) warrants particular consideration. The olfactory epithelium’s sensory neurons project cilia directly into the mucus layer and are vulnerable to both chemical toxicity and mechanical shear. Hydrogels intended for middle-meatus or superior-meatus deployment should demonstrate preservation of CBF in air-liquid-interface (ALI) cultures of human olfactory epithelial cells, a testing standard still not universally applied. Recent clinical trials underscore the clinical relevance of these material-science principles. The completed NCT04970966 randomized trial at the University of Southern California compared the RADA16-based PuraSinus with a bioresorbable nasal dressing (PosiSep X) specifically for patient comfort during postoperative debridement, with PuraSinus demonstrating significantly reduced pain scores [117]. The Hur et al. trial similarly confirmed superior comfort of RADA16 peptide hydrogel over chitosan-based polymers in bilateral ESS [117]. These results establish that hydrogels designed with appropriate rheology and surface chemistry can translate directly into clinically measurable comfort benefits. Anti-inflammatory and antimicrobial actions The moist, warm nasal microenvironment, combined with surgical or traumatic mucosal disruption, readily supports bacterial proliferation and biofilm formation. Resulting infection triggers a chronic inflammatory cascade—neutrophil infiltration, ROS burst, pro-inflammatory cytokine release—that causes oxidative damage and impedes re-epithelialization [124]. Bacterial biofilms, functioning as physical and chemical barriers, further resist immune attack and antibiotic penetration, establishing recalcitrant infectious foci [125]. Critically, broad-spectrum antimicrobial strategies risk exacerbating the sinonasal microbiome dysbiosis characteristic of chronic rhinosinusitis (Section “The sinonasal microbiome”) [39, 40]. Rational hydrogel design therefore requires targeted, mechanism-specific antimicrobial action that spares commensals. Li et al. constructed a dual-network hydrogel integrating mesenchymal stem cell-derived exosomes, which synergistically disrupts the “infection-inflammation” cycle through combined physicochemical and biological mechanisms [126]. The carboxymethyl chitosan component provides intrinsic antimicrobial activity through disruption of bacterial membrane integrity by its cationic groups—a mechanism that preferentially targets pathogens over the neutral commensals dominant in the healthy sinonasal microbiome. Exosomes delivered via nasal epithelial uptake modulate the immune microenvironment, suppressing neutrophil infiltration and pro-inflammatory cytokine storm. In vitro and in vivo studies confirmed inhibition of S. aureus growth and, via α-smooth muscle actin downregulation, blockade of the fibroblast-to-myofibroblast transition driving scar formation. Yathavan et al. developed a SELP-based thermoresponsive hydrogel delivering silver nanoparticles and HA, designed to prevent S. aureus and P. aeruginosa biofilms following chronic rhinosinusitis surgery [51]. The system is liquid at room temperature (facilitating injection into irregular cavities) and rapidly gels at body temperature, enabling sustained silver nanoparticle release. In vitro, anti-biofilm efficacy was comparable to ciprofloxacin, while the HA component inhibited IL-6 and IL-8 release from LPS-stimulated macrophages. This integrated “anti-biofilm + anti-inflammatory” strategy exemplifies rational design for chronic rhinosinusitis settings. Chen et al. demonstrated a PATA multifunctional injectable hydrogel combining PVA, the TSPBA diboronic acid crosslinker, GelMA microgels loaded with sodium fusidate, and metformin-containing nanoliposomes [127]. Although originally developed for diabetic wounds, this platform illustrates design principles directly transferable to nasal applications: ROS-responsive degradation (via boronic ester cleavage, Section “ROS-responsive hydrogels”) achieves > 60% reduction of intracellular ROS, while sodium fusidate targets bacterial elongation factor G (FusA) for > 98% kill rate against MSSA and MRSA. The 15-day sustained release timeline matches the critical window of nasal mucosal re-epithelialization. Critical evaluation Antimicrobial hydrogels face several tensions between efficacy and microbiome preservation. Silver-releasing systems have documented broad-spectrum activity but may impair ciliary function at cumulative high doses. Cationic polymer hydrogels (chitosan, ε-polylysine) offer selective activity against pathogens but can lose function when saturated by mucin binding. Future designs integrating selective bacteriocin delivery or targeting pathogen-specific quorum-sensing molecules may achieve therapeutic benefit while preserving commensal community structure. Applications in post-surgical nasopharyngeal carcinoma care Nasopharyngeal carcinoma (NPC) is a clinically significant malignancy prevalent in Southeast Asia and southern China, typically treated by combined radiotherapy and chemotherapy with or without surgical intervention. Post-treatment management faces distinctive challenges: radiation-induced mucositis, xerostomia, delayed wound healing driven by microvascular damage, chronic oxidative stress, and heightened risk of secondary infection—conditions that severely compromise patient quality of life and can delay or require modification of oncological treatment [128, 129]. Functional hydrogels offer a uniquely compelling platform for integrated NPC management, combining antitumor, anti-inflammatory, and wound-healing functions. Ni et al. developed a gelatin-sodium alginate (Gel-SA) hydrogel loaded with Bi₂Se₃ nanosheets that delivers an integrated photothermal/photodynamic antitumor therapy followed by anti-inflammatory and wound-healing support [130]. Under near-infrared irradiation, Bi₂Se₃ nanosheets generate ROS and heat, inducing tumor cell ferroptosis and apoptosis through the p53-SLC7A11-GPX4 and p62-NRF2 pathways. Once photothermal therapy concludes, the same nanosheets scavenge residual ROS, while Gel-SA provides nutrient support and scaffolding for mucosal regeneration. This “all-in-one” strategy addresses the paradox that aggressive antitumor therapy and wound healing have traditionally required opposing microenvironments. Beyond this specific system, hydrogel-based local drug delivery for radiation sensitization and mucositis management is an expanding research frontier. Xu et al. systematically reviewed injectable hydrogels for enhancing radiotherapy efficacy, highlighting thermosensitive chitosan/β-glycerophosphate systems for local cisplatin delivery in head-and-neck cancers [128]. Shu et al. comprehensively reviewed hydrogel strategies for treating radiation-induced skin and mucosal damage, with direct applicability to head-and-neck radiation contexts [129]. Translational outlook Key design considerations specific to post-NPC nasal repair include (i) antioxidant scavenging capacity tuned to chronic rather than acute ROS burst; (ii) pro-angiogenic factor delivery (VEGF, bFGF) to address radiation-induced microvascular rarefaction; (iii) compatibility with concurrent chemoradiation; and (iv) anatomical adaptation to the nasopharyngeal cavity, which is more posterior and access-limited than the anterior nasal cavity typically addressed in FESS. Integrated platforms combining these features with mucoadhesive, mucosa-compatible properties represent an important future research direction [130]. Cell–material interactions at the hydrogel–mucosa interface Beyond macroscopic therapeutic outcomes, the fundamental biological mechanisms by which hydrogels drive nasal wound healing are rooted in cell–material interactions at the hydrogel–mucosa interface. Three cellular systems are of particular importance: nasal epithelial cells and fibroblasts; resident and infiltrating macrophages; and the ciliated columnar epithelium of the mucociliary clearance apparatus. Mechanical cues regulating nasal epithelial and fibroblast behavior Mechanical properties—stiffness, viscoelasticity, and surface topography—are potent regulators of cellular phenotype, often superseding biochemical cues [102, 132]. For nasal epithelial cells, substrates matching the native mucosal Young’s modulus (≈ 1–10 kPa) promote coordinated migration and re-epithelialization, whereas excessively stiff substrates (> 50 kPa) can drive epithelial-to-mesenchymal transition (EMT) and impair barrier function [132]. Viscoelasticity—the capacity to stress-relax—is particularly influential: dynamic, stress-relaxing hydrogels (such as those crosslinked with boronic esters or Schiff bases) allow cells to remodel the matrix during migration and 3D organization, while elastic hydrogels (UV-crosslinked GelMA, covalent PEG) confine cells and can inhibit proliferation [101, 133]. For fibroblasts at the nasal wound edge, substrate stiffness directly modulates their differentiation into pro-fibrotic myofibroblasts. Stiff substrates (> 20 kPa) activate α-smooth muscle actin expression and drive excessive collagen deposition, the core pathway of pathological scarring [133]. Soft-but-viscoelastic hydrogels (1–5 kPa, rapidly stress-relaxing) suppress this pathway, favoring physiological remodeling. This insight explains why dynamic covalent hydrogels such as CG chitosan-gluconate [75] and RADA16 peptide [52] show superior anti-fibrotic outcomes despite their relatively modest moduli. Surface topography and micro-scale porosity further modulate cell behavior. Micro-channels aligned parallel to the mucosal surface direct epithelial cell migration along the wound axis; interconnected pores (50–200 μm) allow infiltration of progenitor cells and angiogenic support [133]. Hydrogel-driven macrophage polarization (M1→M2 transition) Macrophages are pivotal orchestrators of the inflammation-to-resolution transition in wound healing. Pro-inflammatory M1 macrophages dominate the early phase, secreting TNF-α, IL-1β, and iNOS-derived nitric oxide; anti-inflammatory M2 macrophages dominate resolution, secreting IL-10, TGF-β, and VEGF that drive angiogenesis and tissue remodeling. Persistent M1 dominance—characteristic of chronic nasal inflammation—delays healing and drives fibrosis [134, 135]. Hydrogel chemistry and mechanics directly modulate macrophage polarization through several mechanisms. Functional groups: cationic surfaces tend to drive M1 polarization, while neutral and zwitterionic surfaces favor M2; catechol-containing hydrogels (inspired by dopa) drive M2 polarization through TLR4-independent pathways [134]. Stiffness: in soft-tissue contexts, recent systematic studies have shown that low-kPa stiffness differences (even within the 1–10 kPa range) can influence polarization, with generally softer viscoelastic substrates favoring M2 [136]. Dynamic mechanical properties: catalyst-tuned dynamic hydrogels have been shown to drive M2 polarization through JAK/STAT signaling, independent of stiffness changes [137]. Degradation products: chitosan oligosaccharides (from lysozyme degradation), hyaluronic acid fragments of specific molecular weights (100–500 kDa favor M2; short fragments favor M1), and boronic acid byproducts all exert direct immunomodulatory effects [46]. For nasal wounds specifically, the chronic inflammation driven by recurrent infection and biofilm formation often traps macrophages in M1; rationally designed hydrogels can actively shift this balance. Chen et al.‘s dynamic HA-dopamine/PBA hydrogel, originally validated in diabetic wounds, drives M2 polarization via the JAK/STAT pathway [137]; its design principles—dynamic covalent network with dopamine and boronic ester motifs—are directly applicable to nasal applications. The exosome-loaded dual-network hydrogel of Li et al. [126] exploits a parallel strategy through exosomal miRNA-mediated immunomodulation. Hydrogel interaction with the mucociliary clearance apparatus Perhaps the most uniquely nasal concern at the cell–material interface is the hydrogel’s interaction with the ciliated columnar epithelium and the MCC apparatus. Two critical questions arise: does the hydrogel temporarily paralyze ciliary beating, and does it support or impair ciliary regeneration? Healthy ciliary beat frequency (CBF) is ≈ 10 Hz in ex vivo measurements and ≈ 8 Hz in air-liquid-interface cultures of human nasal epithelial cells [36, 138]. Chemical insult by preservatives (benzalkonium chloride), surfactants, or high-ionic-strength formulations can reduce CBF reversibly or irreversibly [35, 139]. Hydrogel degradation products should therefore be screened for ciliotoxicity using standard ALI assays. Encouragingly, most well-designed hydrogels (chitosan/dextran, RADA16, HA-based) have shown preserved CBF in available studies; non-diluted seawater-based formulations even enhanced CBF and accelerated epithelial wound repair in ALI models [140]. Mechanically, recent evidence indicates that compressive stress ≥ 1.0 kPa applied to the epithelial surface can enhance CBF and mucociliary transport through cytoskeletal remodeling [34]. This surprising finding suggests that hydrogels tuned to this threshold may actively support mucociliary function rather than impair it—a design target that has not been systematically exploited. For ciliary regeneration after injury, hydrogel scaffolds can play a supportive role by providing a stable, moist, biochemically favorable environment. Tri-culture models combining epithelial, endothelial, and stromal cells in fibrin hydrogels have demonstrated the capacity to regenerate ciliated mucosa with CBF of 6–8 Hz over 28 days [141]—a platform that may in the future enable testing of nasal hydrogel candidates for supporting ciliary recovery. Summary of the cell–material interface Rationally designed nasal hydrogels are not passive fillers but active modulators of the wound microenvironment, shaping epithelial migration, fibroblast fate, macrophage polarization, and ciliary recovery through their mechanical, chemical, and degradation characteristics. This paradigm shift from passive barrier to active biological regulator fundamentally changes the translational pathway from material design to clinical outcome. Figure 4 consolidates the key cell–material interactions at the hydrogel–mucosa interface, highlighting how wet adhesion, ciliary compatibility, macrophage polarization, and fibroblast regulation are orchestrated by hydrogel physicochemical properties. Cell–material interactions at the hydrogel–mucosa interface. Functional nasal hydrogels act not merely as passive fillers but as interfacial regulators of mucosal repair. At the hydrogel–mucus–epithelium interface, wet adhesion is mediated by hydration, electrostatic interactions, reversible boronic ester–diol binding, catechol-associated interfacial bonding, and other mucin-related interactions, while ciliary compatibility remains essential for preserving mucociliary clearance. Hydrogel physicochemical cues, including ROS scavenging, viscoelasticity, surface chemistry, and bioactive degradation products, may promote macrophage transition from a pro-inflammatory M1-like phenotype toward a more reparative M2-like phenotype. Matrix stiffness and stress relaxation further influence fibroblast migration, myofibroblast differentiation, ECM deposition, and fibrotic versus regenerative outcomes. Optimized nasal hydrogels should therefore balance residence time, wet adhesion, mechanical compliance, degradation, and CBF preservation to support epithelial recovery without impairing mucociliary function Conclusions, challenges, and future perspectives This review has systematically surveyed functional hydrogels for nasal wound healing from a materials-science-focused perspective. Three overarching conclusions emerge. First, the physicochemical microenvironment of the nasal cavity—acidic mucosal pH (6.3–6.9), shear-thinning mucus rheology (0.1–1 Pa·s healthy, rising to 1.6–3.2 Pa·s in CRS), hydrodynamic shear from mucociliary clearance, physiological temperature of 30–34 °C, enzymatic activity dominated by lysozyme, and a commensal-dominant microbiome—establishes specific “gold standards” that any nasal hydrogel must meet. Second, rational classification by polymer backbone and crosslinking chemistry (dynamic covalent vs. supramolecular) reveals that wet tissue adhesion—the core design challenge—is determined less by polymer choice than by the crosslinking strategy, with catechol, boronic ester, and Schiff-base chemistries leading current practice. Third, the rate constants and reaction pathways of stimuli-responsive motifs must be quantitatively matched to the pathological trigger concentrations and kinetic windows of the nasal wound, not merely assumed to function in vivo based on in vitro responsiveness. Beyond passive packing, functional hydrogels are emerging as active modulators of the wound microenvironment through macrophage polarization, fibroblast fate determination, and support of ciliary regeneration. Multiple clinical trials—several discussed in Table 2—confirm that rational material design translates into measurable clinical benefit in hemostasis, synechiae prevention, and patient comfort. Nonetheless, several significant translational challenges remain. Sterilization Hydrogels are particularly vulnerable to sterilization-induced degradation. Gamma irradiation can fragment polymer backbones and generate reactive radicals that cross-react with embedded drugs or bioactive factors; ethylene oxide exposure leaves cytotoxic residues that must be fully purged and can alter crosslinking chemistry; autoclaving destroys most protein-containing hydrogels and thermally triggers gelation in thermoresponsive systems. Filter sterilization is limited to pre-gelled liquid precursors. For peptide and polysaccharide hydrogels, aseptic processing under GMP remains the only broadly applicable route, substantially increasing manufacturing cost [142]. Innovative alternatives—such as in situ sterilization by supercritical CO₂ or low-temperature plasma—are emerging but not yet mainstream. Standardized large-scale production and cost Translation from bench-scale synthesis to reproducible clinical batches requires rigorous quality control over polymer molecular weight, crosslinking density, rheology, and sterility. Peptide-based systems (e.g., RADA16) face particular cost pressure due to solid-phase synthesis economics, while natural polymer systems face variability in source material (e.g., chitosan deacetylation, hyaluronic acid molecular weight from bacterial fermentation vs. animal extraction). Cost-effectiveness analyses remain scarce; widespread adoption of advanced hydrogels over simple packing materials requires demonstration of outcome-based savings (reduced re-operation, shorter recovery, fewer follow-up visits). Long-term in vivo safety and degradation product fate Most reported nasal hydrogel studies follow patients/animals for 2–12 weeks. Long-term (6-month to multi-year) outcomes regarding chronic inflammation, residual polymer fragments, and their potential systemic absorption remain poorly characterized. Particular concerns include boronic acid byproduct accumulation, residual thermoresponsive polymer (pNIPAAm is non-degradable), and silver nanoparticle systemic redistribution. Microbiome preservation As emphasized in Section “The sinonasal microbiome” and anti-inflammatory and antimicrobial actions, aggressive broad-spectrum antimicrobial hydrogels may exacerbate the microbial dysbiosis that itself contributes to CRS pathogenesis. Future designs should incorporate mechanism-specific, commensal-sparing antimicrobial strategies—targeted bacteriocin delivery, quorum-sensing inhibitors, or probiotic-loaded hydrogels—while maintaining efficacy against pathogens and biofilms. Head-to-head clinical comparisons With multiple commercial products (MeroGel, PureRegen Gel Sinus, Chitogel, PuraGel/PuraSinus, Nasopore) in routine use, comparative effectiveness trials with standardized outcomes (re-epithelialization rate, synechiae score, patient-reported comfort, sinonasal QOL) are urgently needed to guide evidence-based product selection. Personalization Variation in sinonasal microbiome composition, host inflammatory phenotype (Th1/Th2/Th17), and mucus rheology suggests that a one-size-fits-all hydrogel may be suboptimal. Future platforms may stratify patients based on microbiome profiling or mucosal biomarkers and tailor hydrogel composition accordingly. Integrated therapeutic platforms The convergence of functional hydrogels with adjacent technologies—photothermal therapy for NPC, combined anti-inflammatory/anti-fibrotic/anti-infective multimodal delivery, biosensor-integrated smart dressings, and bioprinted patient-specific implants—represents the frontier of the field. In conclusion, functional hydrogels have transitioned from passive fillers to active modulators of the nasal wound microenvironment, with rational material-science design principles now demonstrably translating into clinical benefit. The continued integration of chemistry, materials science, rhinology, and immunology—alongside rigorous attention to the persistent challenges of sterilization, safety, cost, and microbiome preservation—will drive the next generation of precision, personalized, and intelligent nasal wound management. Acknowledgements Not applicable. Author contributions Conceptualization: WCY, GSQ; Methodology: WCY, GSQ; Investigation: WCY, HB, TYJW; Visualization: WCY, HB, TYJW; Funding acquisition: YD; Project administration: WCY, YD; Supervision: WCY, YD; Writing-original draft: WCY, WZK, ZYJ; Writing-review and editing: WCY, WZK, YD, ZYJ. Funding This work was supported by grants from Ningbo Top Medical and Health Research Program (No. 2023030514), Ningbo Clinical Research Center for Otolaryngology Head and Neck Disease (No. 2022L005), 2024 Ningbo Public Welfare Science and Technology Plan Key Project (No. 2024S032), Ningbo Natural Science Foundation (No. 2023J213), The key project of the Ningbo Education Science Planning in 2025 (No. 2025YZD001), 2024 Teaching and Research Project of Ningbo University (No. JYXM2024122), 2022 postgraduate course construction project of Medical School of Ningbo University, Key Project of Huili Foundation (No. 2022ZD003), Ninghai Science and Technology Project (No. 05), and Ningbo Public Welfare Science and Technology Project (No.2025S169). Data availability No datasets were generated or analysed during the current study. Declarations Ethical approval and consent to participate Not applicable. This is a review paper and does not involve direct research on humans or animals. Consent for publication “Not applicable” as this manuscript does not contain data from any person. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.